What is Cbset?
CBSET, a not-for-profit biomedical research institute based in Lexington, Mass., is dedicated to accelerating scientific, regulatory, and commercial objectives for its sponsors through innovative preclinical services. The company operates a 40,000-square-foot facility that is GLP-compliant and equipped with advanced capabilities including vivaria, specialized procedure rooms, imaging labs, surgical and necropsy suites, and histopathology services. CBSET integrates in vivo and in vitro studies with computational modeling and complex histopathology to provide comprehensive research solutions for the pharmaceutical, medical device, and academic sectors.
How much funding has Cbset raised?
Cbset has raised a total of $2.2M across 2 funding rounds:
Debt
$1M
Debt
$1.2M
Debt (2020): $1M with participation from PPP
Debt (2021): $1.2M led by PPP
What's next for Cbset?
The substantial enterprise-level funding indicates CBSET is poised for significant expansion and further development of its integrated research paradigm. This strategic capital infusion will likely fuel advancements in its preclinical service offerings, enabling the institute to tackle more complex research challenges and solidify its position as a leader in biomedical innovation. The company's focus on combining diverse research methodologies suggests a strategy aimed at enhancing the efficiency and efficacy of drug and device development pipelines.
See full Cbset company page
